Medfinder
Back to blog

Updated: January 27, 2026

Lubiprostone Drug Interactions: What to Avoid and What to Tell Your Doctor

Author

Peter Daggett

Peter Daggett

Drug interaction warning between two medications

Lubiprostone (Amitiza) has a clean interaction profile with no CYP450 interactions — but methadone can reduce its effectiveness. Here's what to tell your doctor.

One of the advantages of Lubiprostone (Amitiza) is its relatively clean drug interaction profile. Because it acts locally in the gut with minimal systemic absorption, it doesn't go through the same liver enzyme pathways (CYP450 system) that are responsible for most drug-drug interactions. This makes it safer to use alongside many other medications. That said, there are important interactions to know about — particularly with opioids — and a complete medication review with your doctor is always warranted.

No CYP450 Interactions: What This Means for Patients

Most drug-drug interactions occur when two medications compete for the same liver enzymes — specifically the CYP450 enzyme system — that metabolize drugs in the body. If one drug blocks an enzyme, it can cause another drug to build up to dangerous levels, or be broken down too quickly to be effective.

Lubiprostone is metabolized locally in the stomach and jejunum through a different pathway — carbonyl reductase — not through the hepatic CYP450 system. This means no clinically significant CYP450-mediated drug interactions are expected with Lubiprostone. Patients on complex medication regimens for heart disease, diabetes, depression, or other conditions don't need to worry about Lubiprostone interfering with those drugs through this common interaction pathway.

The Most Important Interaction: Diphenylheptane Opioids (Methadone)

The most clinically significant drug interaction with Lubiprostone involves a specific class of opioids called diphenylheptane opioids. The primary drug in this class is:

  • Methadone (Dolophine, Methadose): Non-clinical studies show that methadone dose-dependently reduces the activation of ClC-2 channels by Lubiprostone in the gastrointestinal tract. In plain terms, methadone may directly block Lubiprostone's mechanism of action — the very ClC-2 channels that Lubiprostone is trying to open.

As a result, the FDA label explicitly states that the effectiveness of Lubiprostone for opioid-induced constipation (OIC) has not been established in patients taking methadone. If you take methadone for pain management or opioid use disorder treatment, tell your prescriber — Lubiprostone may not work as effectively for you, and a different OIC treatment (such as naloxegol or naldemedine) may be more appropriate.

Other Opioids: Less Concern, But Worth Mentioning

Non-clinical studies also found that other classes of opioids (morphine, fentanyl, oxycodone, hydrocodone, tramadol) had much less effect on ClC-2 channel activation compared to methadone. Lubiprostone is actually FDA-approved for OIC caused by these more common opioids, and clinical trials showed it to be effective in those patients.

Still, if you take any opioid medication, tell your prescriber when starting Lubiprostone. The combination of Lubiprostone-induced diarrhea with opioid-related effects can sometimes create unpredictable bowel symptoms that require monitoring.

Interactions to Watch: Medications That Affect Blood Pressure

Lubiprostone has been associated with syncope (fainting) and hypotension (low blood pressure) in post-marketing reports. While these are not classical drug-drug interactions, patients taking blood pressure-lowering medications (antihypertensives, diuretics) or medications that can cause dehydration should use caution. Vomiting or diarrhea caused by Lubiprostone can worsen dehydration and increase the risk of hypotension — especially in the first hour after a dose.

Relevant medication categories to discuss with your doctor:

  • ACE inhibitors and ARBs (lisinopril, losartan, etc.)
  • Beta-blockers (metoprolol, atenolol)
  • Diuretics (furosemide, hydrochlorothiazide)
  • Other medications with vasodilating or blood-pressure-lowering effects

Pregnancy and Hormonal Medications

Lubiprostone is Pregnancy Category C. Women of childbearing potential must have a negative pregnancy test before starting, and contraception is required during treatment. If you take hormonal contraceptives or fertility medications, tell your doctor before starting Lubiprostone — there are no known direct pharmacokinetic interactions, but the requirement for effective contraception means this conversation is important.

What Medications to Tell Your Doctor About

Before starting Lubiprostone, give your prescriber a complete list of ALL medications, including:

  • All opioid pain medications (especially methadone)
  • Blood pressure medications
  • Diuretics (water pills)
  • All vitamins, supplements, and herbal products (even those that seem unrelated)
  • Any OTC medications you take regularly

The Bottom Line

Lubiprostone has one of the cleaner drug interaction profiles of any prescription constipation medication. The main concern is methadone, which may reduce its effectiveness. For everything else, the absence of CYP450-based interactions means it fits well alongside most medication regimens. See our guide on Lubiprostone side effects for the full safety picture. And when you're ready to fill your prescription, medfinder can help you locate it in stock near you.

Frequently Asked Questions

Lubiprostone has a relatively clean drug interaction profile. Because it's metabolized locally in the gut (not through the liver's CYP450 system), it doesn't have the typical enzyme-based drug interactions common to many other medications. The most clinically significant interaction is with methadone, which may reduce Lubiprostone's effectiveness.

Non-clinical studies show methadone dose-dependently reduces ClC-2 channel activation by Lubiprostone, potentially blocking its mechanism of action. The FDA label states that Lubiprostone's effectiveness for OIC has not been established in patients taking methadone. If you take methadone, talk to your doctor — a PAMORA (like naloxegol or naldemedine) may be a better option for OIC.

Yes, in most cases. Lubiprostone is FDA-approved for opioid-induced constipation caused by morphine, oxycodone, fentanyl, hydrocodone, tramadol, and other non-diphenylheptane opioids. These opioids had much less effect on ClC-2 channels in non-clinical studies than methadone. However, always tell your doctor about all opioids you're taking when starting Lubiprostone.

There are no known CYP450-based pharmacokinetic interactions between Lubiprostone and antidepressants or blood pressure medications. However, Lubiprostone can cause hypotension (low blood pressure) and syncope in some patients. If you take blood pressure medications or diuretics, discuss this with your doctor, particularly if you experience dizziness or lightheadedness after starting Lubiprostone.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Lubiprostone also looked for:

Linaclotide (Linzess)Plecanatide (Trulance)Prucalopride (Motegrity)Naloxegol (Movantik)

31,889 have already found their meds with Medfinder.

Start your search today.

31K+
5-star ratingTrusted by 31,889 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?